Back to NBIX
Assenagon Asset Management S.A. → NBIX
Assenagon Asset Management S.A. NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
6
Latest value
$20.7M
Q3 2026
Peak value
$37.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $6.6M |
| Q4 2025 | $11.3M |
| Q1 2026 | $12.1M |
| Q2 2026 | $37.5M |
| Q2 2026 | $37.5M |
| Q3 2026 | $20.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $20.7M | 145.8K | — | — |
| Q2 2026 | $37.5M | 222.6K | — | — |
| Q2 2026 | $37.5M | 222.6K | — | — |
| Q1 2026 | $12.1M | 91.5K | — | — |
| Q4 2025 | $11.3M | 80.0K | — | — |
| Q3 2025 | $6.6M | 46.9K | — | — |
Other funds holding NBIX
$1.3B
$1.3B
$1.2B
$1.1B
$997.5M
$967.6M
$941.2M
$917.9M